BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12107265)

  • 1. Survivin gene expression in endometriosis.
    Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Yamaguchi H; Akise D; Hung YC; Ueki M
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3452-9. PubMed ID: 12107265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis.
    Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Hung YC; Ueki M
    Gynecol Endocrinol; 2002 Oct; 16(5):391-402. PubMed ID: 12587534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues.
    Londero AP; Calcagno A; Grassi T; Marzinotto S; Orsaria M; Beltrami CA; Marchesoni D; Mariuzzi L
    Virchows Arch; 2012 Nov; 461(5):589-99. PubMed ID: 23011643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional expression of survivin and its splice variants in endometriosis.
    Fujino K; Ueda M; Takehara M; Futakuchi H; Kanda K; Yamashita Y; Terai Y; Ueki M
    Mol Hum Reprod; 2006 Jun; 12(6):383-8. PubMed ID: 16644787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.
    Uzan C; Cortez A; Dufournet C; Fauvet R; Siffroi JP; Daraï E
    Virchows Arch; 2004 Dec; 445(6):603-9. PubMed ID: 15452706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium.
    Chung HW; Lee JY; Moon HS; Hur SE; Park MH; Wen Y; Polan ML
    Fertil Steril; 2002 Oct; 78(4):787-95. PubMed ID: 12372458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis.
    Watanabe A; Taniguchi F; Izawa M; Suou K; Uegaki T; Takai E; Terakawa N; Harada T
    Hum Reprod; 2009 Dec; 24(12):3172-9. PubMed ID: 19729377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
    Bruner-Tran KL; Eisenberg E; Yeaman GR; Anderson TA; McBean J; Osteen KG
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4782-91. PubMed ID: 12364474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis].
    Qiu F; Gao XM; Luo GL; Yang KX; Wang H; Liu H; Wen Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):118-22. PubMed ID: 16468658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis.
    Hudelist G; Keckstein J; Czerwenka K; Lass H; Walter I; Auer M; Wieser F; Wenzl R; Kubista E; Singer CF
    Fertil Steril; 2005 Oct; 84 Suppl 2():1249-56. PubMed ID: 16210018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of the survivin gene in the scar endometriosis and in normal human endometrium].
    Tarkowski R; Kotarski J; Polak G; Wojcierowski J
    Ginekol Pol; 2001 Dec; 72(12A):1539-42. PubMed ID: 11883311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.
    Pan H; Sheng JZ; Tang L; Zhu R; Zhou TH; Huang HF
    Fertil Steril; 2008 Oct; 90(4):1000-7. PubMed ID: 17888430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in endometriosis].
    Li Y; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):30-3. PubMed ID: 16635325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay.
    Ramón L; Gilabert-Estellés J; Castelló R; Gilabert J; España F; Romeu A; Chirivella M; Aznar J; Estellés A
    Hum Reprod; 2005 Jan; 20(1):272-8. PubMed ID: 15579491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis.
    Gaetje R; Holtrich U; Engels K; Kourtis K; Cikrit E; Kissler S; Rody A; Karn T; Kaufmann M
    Gynecol Endocrinol; 2007 Oct; 23(10):567-73. PubMed ID: 17952761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.